Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joe T. Collins is active.

Publication


Featured researches published by Joe T. Collins.


Heterocycles | 1994

The N-Boc Group as an Activator for the a-Lithiation of Carbamates: Synthesis of 11-Substituted Dibenzoxazepines

Timothy J. Hagen; Michael F. Rafferty; Joe T. Collins; Danny J. Garland; James J. Li; Monica B. Norton; David B. Reitz; Sofya Tsymbalov; Barnett S. Pitzele; E. Ann Hallinan

A series of 11-substituted dibenzoxazepines was prepared via α-lithiation utilizing the N-Boc group as an activator. The N-Boc group directs metalation of 5 by n-BuLi to the benzylic C-11 carbon. For 6 which contains 1,3 interrelated directed metalation groups, metalation with n-BuLi occurs at both the 11- and 9- positions. The regioselectivity for the lithiation of 6 can be increased to a ratio of 97:3, by employing LDA as the base, thus providing a convenient and general route to 11-substituted 8-chloro-dibenzoxazepines. By the proper choice of the base, the regioselectivity of lithiation-substitution reactions in the pharmaceutically important heteroaromatic ring systems (5) and (6) can be controlled. The N-Boc group can be readily removed with mild acid treatment


Archive | 1990

Cycloheptimidazolone compounds as angiotensin II antagonists for control of hypertension

Philippe R. Bovy; Joan M. O'Neal; Timothy S. Chamberlain; Joe T. Collins


Archive | 1991

1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS

Philippe R. Bovy; Timothy S. Chamberlain; Joe T. Collins


Archive | 1994

Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical compositions and methods of use

Joe T. Collins; Donald W. Hansen; Karen B. Peterson; Barnett S. Pitzele; David B. Reitz


Archive | 1997

Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists

Philippe R. Bovy; Joe T. Collins; Robert E. Manning


Archive | 1999

Amino benzenepropanoic acid compounds and derivatives thereof

Joe T. Collins; Balekudru Devadas; Hwang-Fun Lu; James W. Malecha; Julie M. Miyashiro; Srinivasan Nagarajan; Joseph G. Rico; Thomas E. Rogers


Archive | 1991

Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders

Philippe R. Bovy; Joe T. Collins; Timothy S. Chamberlain; Brian K. Gheng


Archive | 1993

Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists

Philippe R. Bovy; Joe T. Collins; Robert E. Manning


Synlett | 2011

A Practical Synthesis of [(1S,3S)-3-Aminocyclohexyl]methanol and 2-[(1S,3S)-3-Aminocyclohexyl]propan-2-ol, Useful Intermediates for the Preparation of Novel mPGES-1 Inhibitors

Daniel P. Walker; Steven E. Heasley; Allison MacInnes; Tizah Evelyn Anjeh; Hwang-Fun Lu; Yvette M. Fobian; Joe T. Collins; Michael L. Vazquez; Michael K. Mao


Archive | 1991

COMPOSES DE [4,5-d]PYRIDAZINE IMIDAZO A SUBSTITUTION 1H UTILISES DANS LE TRAITEMENT DE TROUBLES CARDIOVASCULAIRES

Philippe R. Bovy; Timothy S. Chamberlain; Joe T. Collins

Collaboration


Dive into the Joe T. Collins's collaboration.

Top Co-Authors

Avatar

Philippe R. Bovy

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Timothy J. Hagen

Northern Illinois University

View shared research outputs
Researchain Logo
Decentralizing Knowledge